Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-10-01FDA Approved: NERLYNX — Supplemental Application (Puma Biotechnology, Inc.)
The FDA approved a supplemental application for Nerlynx (neratinib) submitted by Puma Biotechnology, Inc. This action updates the drug’s lab…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial [Phase 2]
Phase II trial investigating zafirlukast, a leukotriene inhibitor, for breast capsular contracture after post-mastectomy reconstruction; stu…
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer. [Phase 4]
Phase 4 clinical trial update evaluating the incidence of chemotherapy-induced nausea and vomiting with docetaxel-cyclophosphamide in early …
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography [NA]
Completed clinical trial of dual-energy contrast-enhanced digital mammography for breast cancer; results posted in 2019.
-
FDA approval · 2019-09-24FDA Approved: TALZENNA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TALZENNA (talazoparib) submitted by Pfizer Laboratories Div Pfizer Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer [Phase 4]
Phase 4 trial update assessing safety of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block [Phase 4]
A Phase 4 trial comparing levobupivacaine alone versus levobupivacaine with dexmedetomidine for ultrasound-guided pectoral nerve block in br…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer [Phase 2]
Phase 2 trial updates trametinib combined with an AKT inhibitor (GSK2141795) in metastatic triple-negative breast cancer; study completed wi…
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer [Phase 2]
A Phase II trial evaluating Pyrotinib in combination with the CDK4/6 inhibitor SHR6390 in patients with trastuzumab-treated advanced HER2-po…
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating TCHP versus EC-THP as neoadjuvant therapy for HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: LLLT Combined With CDT in Breast Cancer-Related Lymphedema [NA]
Clinical trial update for low-level laser therapy combined with compression therapy in breast cancer-related lymphedema; trial completed wit…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC) [Phase 3]
Phase 3 study evaluating subcutaneous at-home administration of trastuzumab (Herceptin) in HER2-positive early breast cancer; study complete…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy [Phase 2]
Phase II study evaluating curcumin versus placebo in chemotherapy-treated breast cancer patients undergoing radiotherapy has completed with …
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer [Phase 2]
Phase II trial evaluating markers to predict response to a combined therapy in HER2-positive breast cancer, terminated with results posted i…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing vinflunine to an alkylating agent in metastatic breast cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast Cancer [Phase 2]
Phase 2 trial evaluating vitamin D supplementation to correct vitamin D deficiency in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients [Phase 2]
Phase 2 trial update for a recombinant human serum albumin/G-CSF fusion protein in breast cancer patients undergoing chemotherapy, completed…
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating vinflunine plus capecitabine in advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer [Phase 2]
Phase 2 trial comparing docetaxel alone versus docetaxel combined with gemcitabine in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer [Phase 2]
Phase 2 trial evaluating pyrotinib with trastuzumab and an aromatase inhibitor for HER2-positive breast cancer showing ongoing status with n…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer [Phase 1, Phase 2]
Combination of trastuzumab with NK immunotherapy studied in recurrent breast cancer across Phase 1 and Phase 2; trial completed.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for breast cancer (recurrent) has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer [Phase 2]
Phase 2 trial update for etirinotecan pegol in refractory brain metastases, extensive-stage small cell lung cancer, recurrent NSCLC, metasta…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy [Phase 2]
Phase 2 clinical trial evaluating recurrence score-guided chemotherapy in HR-positive, HER2-negative breast cancer after neoadjuvant therapy…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer [Phase 2]
Phase II trial investigating neoadjuvant metronomic chemotherapy in triple-negative breast cancer was terminated with results posted.